Literature DB >> 2435182

The basis of antimalarial action: non-weak base effects of chloroquine on acid vesicle pH.

D J Krogstad, P H Schlesinger.   

Abstract

Biologically active concentrations of chloroquine increase the pH of the parasite's acid vesicles within 3-5 min. This increase in pH results from two mechanisms, one of which is markedly reduced in chloroquine-resistant parasites. Because chloroquine is a weak base, it increases vesicle pH by that mechanism in chloroquine-susceptible and resistant parasites and mammalian cells (based on its two pKs and on the delta pH between the acid vesicle and the extracellular environment). In chloroquine-susceptible parasites, but not resistant parasites or mammalian cells, chloroquine increases the pH of acid vesicles 700- to 800-fold more than can be accounted for by its properties as a weak base. The increase in acid vesicle pH caused by these non-weak base effects of nanomolar chloroquine in susceptible parasites suggests that chloroquine acts by interfering with acid vesicle functions in the parasite such as the endocytosis and proteolysis of hemoglobin, and the intracellular targeting of lysosomal enzymes. The non-weak base effects of nanomolar chloroquine on parasite vesicle pH are also responsible for its safety because these chloroquine concentrations do not affect mammalian cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2435182     DOI: 10.4269/ajtmh.1987.36.213

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  22 in total

1.  Correction of Niemann-Pick type C1 trafficking and activity with the histone deacetylase inhibitor valproic acid.

Authors:  Kanagaraj Subramanian; Darren M Hutt; Samantha M Scott; Vijay Gupta; Shu Mao; William E Balch
Journal:  J Biol Chem       Date:  2020-04-30       Impact factor: 5.157

Review 2.  Antimalarial agents: mechanisms of action.

Authors:  P H Schlesinger; D J Krogstad; B L Herwaldt
Journal:  Antimicrob Agents Chemother       Date:  1988-06       Impact factor: 5.191

Review 3.  Antimalarial agents: mechanism of chloroquine resistance.

Authors:  D J Krogstad; P H Schlesinger; B L Herwaldt
Journal:  Antimicrob Agents Chemother       Date:  1988-06       Impact factor: 5.191

4.  Chloroquine inhibits the intracellular multiplication of Legionella pneumophila by limiting the availability of iron. A potential new mechanism for the therapeutic effect of chloroquine against intracellular pathogens.

Authors:  T F Byrd; M A Horwitz
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

5.  Hyaluronidase Hyal1 Increases Tumor Cell Proliferation and Motility through Accelerated Vesicle Trafficking.

Authors:  Caitlin O McAtee; Abigail R Berkebile; Christian G Elowsky; Teresa Fangman; Joseph J Barycki; James K Wahl; Oleh Khalimonchuk; Naava Naslavsky; Steve Caplan; Melanie A Simpson
Journal:  J Biol Chem       Date:  2015-04-08       Impact factor: 5.157

6.  Evaluation of the Combination of Azithromycin and Naphthoquine in Animal Malaria Models.

Authors:  Zhu-Chun Bei; Guo-Fu Li; Jing-Hua Zhao; Min Zhang; Xiao-Guang Ji; Jing-Yan Wang
Journal:  Antimicrob Agents Chemother       Date:  2020-10-20       Impact factor: 5.191

7.  Multidrug resistance in Leishmania donovani is conferred by amplification of a gene homologous to the mammalian mdr1 gene.

Authors:  D M Henderson; C D Sifri; M Rodgers; D F Wirth; N Hendrickson; B Ullman
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

8.  PEGylated PAMAM dendrimer-doxorubicin conjugates: in vitro evaluation and in vivo tumor accumulation.

Authors:  Saijie Zhu; Minghuang Hong; Lihong Zhang; Guotao Tang; Yanyan Jiang; Yuanying Pei
Journal:  Pharm Res       Date:  2009-10-28       Impact factor: 4.200

Review 9.  Molecular and physiologic basis of quinoline drug resistance in Plasmodium falciparum malaria.

Authors:  Paul D Roepe
Journal:  Future Microbiol       Date:  2009-05       Impact factor: 3.165

10.  Chloroquine reduces arylsulphatase B activity and increases chondroitin-4-sulphate: implications for mechanisms of action and resistance.

Authors:  Sumit Bhattacharyya; Kemal Solakyildirim; Zhenqing Zhang; Robert J Linhardt; Joanne K Tobacman
Journal:  Malar J       Date:  2009-12-17       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.